Pain Therapy: Scientific Update

19
May
2020

Pain Therapy: Scientific Update

Pain Therapy: Scientific Update

Theras' activity alongside pain therapy health professionals does not stop and for this reason we would like to inform you that we have prepared a refresher and comparison course on HF10.

With the aim of giving everyone the opportunity to participate, we have selected two dates, also in view of the requests received.

WHEN:

  • Thursday 21 May, from 17.00 to 19.00;
  • Thursday 28 May, from 17.00 to 19.00.

 

TO SIGN UP

To register, you can contact our contact person or write to us directly at education@theras-group.com, indicating your name, surname and reference structure.

 

HOW TO

The selected platform will be GoToMeeting, a tool dedicated to e-learning, which can be accessed via the link you will receive once registered, and for which it will be necessary to enter the password received.

 

SPEAKER

Isabella Alessandrini, Theras Medical & Scientific Advisor.

 

TOPICS

Nevro: the new pain areas
The state of the art of the new scientific studies on Nevro about the new therapeutic and treatment areas, with an overview of the trend of the most recent studies in the literature and the new frontiers of HF10 therapy.

Pharmacoeconomics of HF10 systems: the winning choice
A complete and analytical overview of the convenience and sustainability of the high technology therapeutic option, with specific regard to HF10 and the Italian reality: from economic models to rescue homes.

Nevro Omnia
An update on the state of the art and upcoming news.


Related news

Life Science Innovation: the ecosystem that brings change

The first workshop of the new Observatory dedicated to Life Science Innovation

Read more

Theras among Italy's top 50 companies as Champions of Growth 2022

Double recognition for Theras Lifetech and Theras Biocare as leaders in technology and innovation

Read more

The most beautiful emotions must be lived without interruptions

Theras tells how and how much technology improves the quality of life for people with chronic diseases.

Read more